Physical activity improves outcomes of combined lenvatinib plus anti-PD-1 therapy in unresectable hepatocellular carcinoma: a retrospective study and mouse model

BACKGROUND: Physical activity is known to have anti-cancer effects, including immunomodulatory actions. This study investigated the hypothesis that physical activity synergizes with combined lenvatinib plus anti-PD-1 therapy to enhance efficacy in patients with unresectable HCC. METHODS: The physica...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xue-Feng, Zhu, Xiao-Dong, Feng, Long-Hai, Li, Xiao-Long, Xu, Bin, Li, Kang-Shuai, Xiao, Nan, Lei, Ming, Sun, Hui-Chuan, Tang, Zhao-You
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978397/
https://www.ncbi.nlm.nih.gov/pubmed/35379324
http://dx.doi.org/10.1186/s40164-022-00275-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978397/
https://www.ncbi.nlm.nih.gov/pubmed/35379324
http://dx.doi.org/10.1186/s40164-022-00275-0

Ejemplares similares